ASHLEY KIM: Open Payments
NPI 1760265367 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 73 payments from 14 companies in 2025. Trend: 2023 $446 · 2024 $1,547 · 2025 $2,274
Food & beverage: $2,099Education: $169Travel & lodging: $6
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $539 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $354 |
| Arcutis Biotherapeutics, Inc. | 9 | $234 |
| GENZYME CORPORATION | 2 | $230 |
| E.R. Squibb & Sons, L.L.C. | 5 | $187 |
| ABBVIE INC. | 10 | $173 |
| Lilly USA, LLC | 6 | $161 |
| Incyte Corporation | 4 | $103 |
| Journey Medical Corporation | 1 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
Products named: NEMLUVIO, Zoryve, Sotyktu, Winlevi, EBGLYSS, OPZELURA, SKYRIZI, DUPIXENT.
Industry payments across CA — which companies pay providers there.
